Billiontoone (NASDAQ:BLLN) CEO Oguzhan Atay Sells 16,667 Shares of Company Stock

by · The Cerbat Gem

Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) CEO Oguzhan Atay sold 16,667 shares of the firm’s stock in a transaction dated Monday, October 12th. The stock was sold at an average price of $93.79, for a total transaction of $1,563,197.93. Following the completion of the sale, the chief executive officer directly owned 16,667 shares of the company’s stock, valued at approximately $1,563,197.93. The trade was a 50.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Oguzhan Atay also recently made the following trade(s):

  • On Monday, October 12th, Oguzhan Atay sold 2,667 shares of Billiontoone stock. The shares were sold at an average price of $97.61, for a total value of $260,325.87.
  • On Monday, September 28th, Oguzhan Atay sold 2,666 shares of Billiontoone stock. The shares were sold at an average price of $120.64, for a total value of $321,626.24.
  • On Monday, September 28th, Oguzhan Atay sold 8,333 shares of Billiontoone stock. The stock was sold at an average price of $120.64, for a total value of $1,005,293.12.
  • On Monday, September 14th, Oguzhan Atay sold 5,332 shares of Billiontoone stock. The stock was sold at an average price of $98.00, for a total value of $522,536.00.
  • On Monday, September 14th, Oguzhan Atay sold 24,999 shares of Billiontoone stock. The stock was sold at an average price of $100.32, for a total value of $2,507,899.68.
  • On Monday, August 3rd, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The shares were sold at an average price of $137.37, for a total value of $1,717,125.00.
  • On Monday, August 3rd, Oguzhan Atay sold 32,500 shares of Billiontoone stock. The shares were sold at an average price of $136.95, for a total value of $4,450,875.00.

Billiontoone Trading Up 3.6%

Billiontoone stock traded up $3.44 during mid-day trading on Wednesday, hitting $97.88. The company’s stock had a trading volume of 424,883 shares, compared to its average volume of 552,974. The company has a debt-to-equity ratio of 0.17, a quick ratio of 11.31 and a current ratio of 11.69. The company has a 50 day moving average of $101.72 and a 200-day moving average of $101.18. Billiontoone, Inc. has a one year low of $61.96 and a one year high of $150.44. The stock has a market cap of $4.62 billion and a PE ratio of 139.83.

Billiontoone (NASDAQ:BLLN – Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.15. The firm had revenue of $109.45 million during the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. On average, research analysts anticipate that Billiontoone, Inc. will post 0.83 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in BLLN. Integrated Wealth Concepts LLC bought a new position in Billiontoone in the second quarter worth approximately $29,000. MCF Advisors LLC lifted its holdings in Billiontoone by 330.8% during the second quarter. MCF Advisors LLC now owns 448 shares of the company’s stock worth $54,000 after buying an additional 344 shares during the period. Family Legacy Financial Solutions LLC bought a new stake in Billiontoone during the 3rd quarter valued at $53,000. Toth Financial Advisory Corp boosted its position in Billiontoone by 60.0% during the 3rd quarter. Toth Financial Advisory Corp now owns 800 shares of the company’s stock valued at $85,000 after acquiring an additional 300 shares in the last quarter. Finally, Thrive Wealth Management LLC bought a new stake in Billiontoone during the 2nd quarter valued at $240,000.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Canaccord Genuity Group initiated coverage on shares of Billiontoone in a report on Wednesday, September 2nd. They set a “buy” rating and a $120.00 price objective for the company. Wall Street Zen lowered shares of Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. BTIG Research decreased their price target on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday, August 6th. Zacks Research upgraded Billiontoone from a “strong sell” rating to a “hold” rating in a report on Friday, October 2nd. Finally, Guggenheim increased their price objective on Billiontoone from $125.00 to $128.00 and gave the stock a “buy” rating in a research note on Thursday, October 1st. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Billiontoone currently has an average rating of “Moderate Buy” and a consensus target price of $126.25.

Get Our Latest Research Report on Billiontoone

About Billiontoone

(Get Free Report)

BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company’s platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.

BillionToOne’s primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.

Further Reading